Tecan Group AG

SWX:TECN 주식 리포트

시가총액: CHF 1.9b

Tecan Group 과거 순이익 실적

과거 기준 점검 0/6

Tecan Group 의 수입은 연평균 -25.5%의 비율로 감소해 온 반면, Life Sciences 산업은 연평균 4.9%의 비율로 증가했습니다. 매출은 연평균 0.9%의 비율로 증가해 왔습니다.

핵심 정보

-25.46%

순이익 성장률

-26.64%

주당순이익(EPS) 성장률

Life Sciences 산업 성장률17.57%
매출 성장률0.88%
자기자본이익률-9.61%
순이익률-12.54%
다음 순이익 업데이트11 Aug 2026

최근 과거 실적 업데이트

분석 기사 Aug 20

Weak Statutory Earnings May Not Tell The Whole Story For Tecan Group (VTX:TECN)

SWX:TECN 1 Year Share Price vs Fair Value Explore Tecan Group's Fair Values from the Community and select yours The...

Recent updates

내러티브 업데이트 May 31

TECN: Reduced P/E Expectations Will Limit Perceived Upside Potential

Analysts have trimmed their price targets on Tecan Group by CHF 1 to CHF 10 in recent updates. This reflects revised assumptions around discount rates, profit margins and future P/E expectations.
내러티브 업데이트 May 02

TECN: Updated Discount Assumptions Will Shape Perceived Upside Potential

Tecan Group's analyst price target has been reduced by CHF 1 to CHF 136, as analysts factor in updated discount rate and valuation assumptions, along with modest adjustments to revenue growth, profit margin and future P/E inputs. Analyst Commentary Recent research points to a more cautious tone around Tecan Group, with reduced price targets reflecting reassessed assumptions on growth, profitability and valuation multiples.
내러티브 업데이트 Apr 18

TECN: AI Lab Collaboration And Execution Discipline Will Support Future Earnings

The analyst price target for Tecan Group has shifted slightly to around CHF 167, with recent CHF 1 and CHF 17 target reductions from different firms. These moves have led analysts to fine tune assumptions on discount rate, revenue growth, profit margin and future P/E, without changing the overall valuation picture in a major way.
내러티브 업데이트 Apr 03

TECN: Mixed Research Views And 2026 Guidance Shape Forward Expectations

Analysts have trimmed their average price target on Tecan Group to CHF 205, a CHF 17 reduction from recent levels. This reflects updated views on discount rates, revenue growth, profit margins and future P/E assumptions following mixed target moves across the Street.
내러티브 업데이트 Mar 20

TECN: AI Lab Collaboration Will Support Forward Efficiency Gains And Earnings

The updated analyst price target for Tecan Group moves to CHF 166.50 from CHF 192.57, reflecting mixed Street views as some analysts trim targets while others highlight support from higher assumed revenue growth and a slightly lower future P/E multiple. Analyst Commentary Recent Street research on Tecan Group points to a split view, with some analysts trimming price targets and others turning more constructive on the shares.
내러티브 업데이트 Mar 05

TECN: Mixed Research Views And Investor Day Outlook Shape Future Expectations

Analysts have trimmed their price target for Tecan Group to CHF 137.00 from CHF 165.20, reflecting updated assumptions around discount rates, revenue growth, profit margins and future P/E. Recent research also includes both a Morgan Stanley target cut and target and rating adjustments from other firms.
내러티브 업데이트 Feb 19

TECN: Recent Upgrade And CHF 205 Goal Will Support Higher Long Term P/E

Analysts have nudged their price targets on Tecan Group slightly lower, with moves such as Morgan Stanley trimming its target by CHF 5 and others, including Bernstein and Berenberg, adjusting their outlooks. These revisions have led to only marginal changes in modeled fair value, discount rate, revenue growth, profit margin, and future P/E assumptions.
내러티브 업데이트 Feb 05

TECN: CFO Transition And Execution Will Support Higher Long Term P/E Potential

Analysts have nudged their price expectations for Tecan Group slightly higher, with the updated fair value estimate moving from CHF 334.71 to about CHF 335.08. This reflects small model adjustments to growth, margins and long term P/E assumptions after recent mixed target moves from banks that both lowered and raised their CHF based price targets.
내러티브 업데이트 Jan 22

TECN: Execution And CFO Transition Will Support Upgraded Outlook And Medium Term Upside

Narrative Update The analyst price target for Tecan Group has been revised to CHF 205 from CHF 200. Analysts cite updated assumptions on growth, profitability and a higher future P/E multiple as the main factors behind this change.
내러티브 업데이트 Jan 08

TECN: Efficiency Gains And Gradual Market Recovery Will Support Forward Earnings

Analysts have trimmed their price target on Tecan Group to about CHF 193 from around CHF 202, reflecting slightly lower fair value estimates, supported by recent target reductions such as the move to CHF 170 cited in Street research. Analyst Commentary Recent Street commentary around Tecan Group points to a more cautious stance, with price targets being reset closer to CHF 170, which sits below the trimmed average around CHF 193.
분석 기사 Dec 23

Does Tecan Group (VTX:TECN) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
내러티브 업데이트 Dec 14

TECN: Medium Term Execution And CFO Transition Will Support Future Upside Potential

Analysts have lowered their price target on Tecan Group to CHF 170 from CHF 177, reflecting a slightly higher discount rate despite modestly improved revenue growth and profit margin expectations. Analyst Commentary Bullish analysts acknowledge the modest reduction in the price target but view the revised CHF 170 level as still supportive of upside potential from current trading levels, given improving fundamentals and execution.
내러티브 업데이트 Nov 30

TECN: Efficiency Gains And Market Recovery Will Drive Forward Earnings Improvements

Analysts have reduced their price target for Tecan Group from CHF 177 to CHF 170. They cited revised market assumptions and modest adjustments to key financial forecasts as reasons for this change.
내러티브 업데이트 Nov 16

TECN: Automation Demand And Partnerships Will Drive Earnings Recovery After 2026

Tecan Group: Analyst Price Target Reduced on Updated Outlook Analysts have lowered their fair value estimate for Tecan Group from CHF 205.98 to CHF 202.48. They cited slightly higher discount rates and tempered expectations for revenue growth and profit margins as reasons for the change.
분석 기사 Nov 06

Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 90% Above Its Share Price

Key Insights Using the 2 Stage Free Cash Flow to Equity, Tecan Group fair value estimate is CHF261 Tecan Group's CHF138...
내러티브 업데이트 Nov 01

TECN: Resilient Demand And Share Repurchase Program Will Drive Shareholder Value

The analyst price target for Tecan Group has been revised downward from CHF 177 to CHF 170. Analysts cite slightly softer revenue growth expectations and a modest increase in the discount rate in their updated assessments.
분석 기사 Oct 22

Should You Investigate Tecan Group AG (VTX:TECN) At CHF150?

Tecan Group AG ( VTX:TECN ), is not the largest company out there, but it saw significant share price movement during...
내러티브 업데이트 Oct 18

Advanced Automation And Personalized Medicine Will Shape Healthcare's Future

Tecan Group's updated analyst fair value price target has been revised downward from CHF 215.73 to CHF 207.23. This change reflects cautious analyst views amid slower revenue growth and tightened profit margin expectations.
내러티브 업데이트 Oct 04

Advanced Automation And Personalized Medicine Will Shape Healthcare's Future

Analysts have adjusted their price target for Tecan Group downward, reducing the fair value estimate from CHF 220.47 to CHF 215.73. This change is due to a slight increase in the discount rate, although forecasts for revenue growth and profit margins have improved.
내러티브 업데이트 Sep 05

Advanced Automation And Personalized Medicine Will Shape Healthcare's Future

Analysts have lowered their outlook for Tecan Group due to concerns over near-term margin pressure, cautious end-market demand, and delayed recovery in key segments, though the consensus price target remained unchanged at CHF220.47. Analyst Commentary Cautious sentiment due to anticipation of "soft" first-half financial results impacting near-term performance.
분석 기사 Sep 04

Tecan Group (VTX:TECN) Has A Pretty Healthy Balance Sheet

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
분석 기사 Aug 20

Weak Statutory Earnings May Not Tell The Whole Story For Tecan Group (VTX:TECN)

SWX:TECN 1 Year Share Price vs Fair Value Explore Tecan Group's Fair Values from the Community and select yours The...
분석 기사 Aug 08

Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 81% Above Its Share Price

Key Insights Tecan Group's estimated fair value is CHF281 based on 2 Stage Free Cash Flow to Equity Current share price...
분석 기사 Jul 21

Why We're Not Concerned About Tecan Group AG's (VTX:TECN) Share Price

When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 20x, you may consider...
분석 기사 May 28

At CHF170, Is Tecan Group AG (VTX:TECN) Worth Looking At Closely?

While Tecan Group AG ( VTX:TECN ) might not have the largest market cap around , it saw a significant share price rise...
분석 기사 Apr 24

Is Tecan Group AG (VTX:TECN) Trading At A 26% Discount?

Key Insights Tecan Group's estimated fair value is CHF199 based on 2 Stage Free Cash Flow to Equity Tecan Group is...
분석 기사 Apr 08

Tecan Group AG (VTX:TECN) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless

To the annoyance of some shareholders, Tecan Group AG ( VTX:TECN ) shares are down a considerable 25% in the last...
분석 기사 Apr 04

Here's Why Shareholders Should Examine Tecan Group AG's (VTX:TECN) CEO Compensation Package More Closely

Key Insights Tecan Group will host its Annual General Meeting on 10th of April Total pay for CEO Achim von Leoprechting...
분석 기사 Apr 01

Is Tecan Group (VTX:TECN) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
User avatar
새로운 내러티브 Mar 16

Expansion Into South Korea And FDA Approval To Support Future High-Value Medical Device Production

Expansion into South Korea and FDA approval in Malaysia bolster Tecan's production and revenue growth potential in medical devices.
분석 기사 Jan 12

Tecan Group AG's (VTX:TECN) Share Price Could Signal Some Risk

When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 20x, you may consider...
분석 기사 Dec 21

A Look At The Fair Value Of Tecan Group AG (VTX:TECN)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Tecan Group fair value estimate is CHF231 With CHF198 share...
분석 기사 Oct 09

Tecan Group AG's (VTX:TECN) P/E Still Appears To Be Reasonable

With a price-to-earnings (or "P/E") ratio of 33.7x Tecan Group AG ( VTX:TECN ) may be sending very bearish signals at...
분석 기사 Sep 21

These 4 Measures Indicate That Tecan Group (VTX:TECN) Is Using Debt Reasonably Well

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
분석 기사 Aug 16

Earnings Report: Tecan Group AG Missed Revenue Estimates By 8.8%

It's been a sad week for Tecan Group AG ( VTX:TECN ), who've watched their investment drop 13% to CHF280 in the week...
분석 기사 Jun 14

Is Tecan Group (VTX:TECN) Using Too Much Debt?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
분석 기사 Apr 20

Calculating The Fair Value Of Tecan Group AG (VTX:TECN)

Key Insights Tecan Group's estimated fair value is CHF409 based on 2 Stage Free Cash Flow to Equity Current share price...

매출 및 비용 세부 내역

Tecan Group가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.


순이익 및 매출 추이

SWX:TECN 매출, 비용 및 순이익 (CHF Millions)
날짜매출순이익일반관리비연구개발비
31 Dec 25882-11120067
30 Sep 25895-2419166
30 Jun 259076318271
31 Mar 259206518370
31 Dec 249346818463
30 Sep 249678518863
30 Jun 241,00010119264
31 Mar 241,03711719267
31 Dec 231,07413219270
30 Sep 231,08812019874
30 Jun 231,10210920578
31 Mar 231,12311520978
31 Dec 221,14412121478
30 Sep 221,11011321279
30 Jun 221,07710521079
31 Mar 221,01211320176
31 Dec 2194712219272
30 Sep 2191113619270
30 Jun 2187515019168
31 Mar 2180312718265
31 Dec 2073110417262
30 Sep 206919416059
30 Jun 206518414956
31 Mar 206447914958
31 Dec 196377314960
30 Sep 196277015059
30 Jun 196166715159
31 Mar 196056914655
31 Dec 185947114151
30 Sep 185827013950
30 Jun 185706913849
31 Mar 185596713750
31 Dec 175496613650
30 Sep 175366213249
30 Jun 175235712948
31 Mar 175155612747
31 Dec 165065512547
30 Sep 164915512345
30 Jun 164765512043
31 Mar 164585611541
31 Dec 154405711040
30 Sep 154345210841
30 Jun 154274810642

양질의 수익: TECN 은(는) 현재 수익성이 없습니다.

이익 마진 증가: TECN는 현재 수익성이 없습니다.


잉여현금흐름 대비 순이익 분석


과거 순이익 성장 분석

수익추이: TECN은 수익성이 없으며 지난 5년 동안 손실이 연평균 25.5% 증가했습니다.

성장 가속화: 현재 수익성이 없어 지난 1년간 TECN의 수익 성장률을 5년 평균과 비교할 수 없습니다.

수익 대 산업: TECN은 수익성이 없어 지난 해 수익 성장률을 Life Sciences 업계(5.4%)와 비교하기 어렵습니다.


자기자본이익률

높은 ROE: TECN는 현재 수익성이 없으므로 자본 수익률이 음수(-9.61%)입니다.


총자산이익률


투하자본수익률


우수한 과거 실적 기업을 찾아보세요

기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/06/10 20:20
종가2026/06/10 00:00
수익2025/12/31
연간 수익2025/12/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
지분 구조10년
  • 주요 주주
  • 내부자 거래
경영진10년
  • 리더십 팀
  • 이사회
주요 개발10년
  • 회사 공시

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드YouTube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Tecan Group AG는 16명의 분석가가 다루고 있습니다. 이 중 8명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
Harry GillisBerenberg
Delphine Le LouetBernstein
Susannah LudwigBernstein